# A Study to Evaluate the Efficacy and Safety of AD-203

> **NCT04066530** · PHASE3 · COMPLETED · sponsor: **Addpharma Inc.** · enrollment: 475 (actual)

## Conditions studied

- Acute Gastritis
- Chronic Gastritis

## Interventions

- **DRUG:** AD-203
- **DRUG:** Mucosta tab.

## Key facts

- **NCT ID:** NCT04066530
- **Lead sponsor:** Addpharma Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-09-23
- **Primary completion:** 2020-02-26
- **Final completion:** 2020-02-26
- **Target enrollment:** 475 (ACTUAL)
- **Last updated:** 2020-12-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04066530

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04066530, "A Study to Evaluate the Efficacy and Safety of AD-203". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04066530. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*